Pharvaris N.V. (PHVS) Financials
PHVS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 179.3 million | 17.2 million |
| 2023-06-30 | 206.3 million | 17.4 million |
| 2023-03-31 | 182.8 million | 20.1 million |
| 2022-12-31 | 180.0 million | 19.8 million |
PHVS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -24.9 million | 3.1 million |
| 2023-06-30 | -22.3 million | 3.0 million |
| 2023-03-31 | -22.3 million | 3.5 million |
| 2022-12-31 | -21.9 million | 3.5 million |
PHVS Net Income
No data available :(
PHVS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 167.6 million | - | 308434 |
| 2023-06-30 | 194.8 million | - | 367984 |
| 2023-03-31 | 176.4 million | - | 421307 |
| 2022-12-31 | 173.7 million | - | 468785 |
PHVS Shares Outstanding
PHVS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 7929 | 19.6 million | 8.1 million | - |
| 2023-06-30 | 38139 | 1.0 million | 480421 | - |
| 2023-03-31 | 25766 | 17.5 million | 8.2 million | - |
| 2022-12-31 | 25368 | 17.2 million | 8.1 million | - |
PHVS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 74007 |
| 2023-06-30 | - | 66966 |
| 2023-03-31 | - | 47969 |
| 2022-12-31 | - | - |
PHVS
Price: $22.60
52 week price:
Earnings Per Share: -3.28 USD
P/E Ratio: -9.48
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 38200
Market Capitalization: 1.2 billion